Concepedia

Maozhang Li

ML

Statistics

Publications

4

Citations

67

H-Index

4

Active since

2020

Affiliations

Huizhou Central People's Hospital(Current)

Guangzhou Medical University

Southern Medical University

Guangzhou First People's Hospital

South China University of Technology

Maozhang Li is an author at Huizhou Central People's Hospital specializing in molecular biology, molecular oncology, and oncology.

ORCID

Publications per year

2020–2023

4

Publications

4

Silencing HOXC13 exerts anti-prostate cancer effects by inducing DNA damage and activating cGAS/STING/IRF3 pathway

Maozhang Li, Guangwei Bai, Yi Cen et al. · Journal of Translational Medicine · 2023 · 20 citations · Full text

, , +17

Genome-Scale CRISPR-Cas9 Transcriptional Activation Screening in Metformin Resistance Related Gene of Prostate Cancer

Jiahong Chen, Yaqiang Huang, Zhenfeng Tang et al. · Frontiers in Cell and Developmental Biology · 2021 · 19 citations · Full text

, , +16

KIF4A: A potential biomarker for prediction and prognostic of prostate cancer

Jiahong Chen, Maozhang Li, Shumin Fang et al. · Clinical and investigative medicine · 2020 · 16 citations · Full text

, , +17

CircPDHX promotes prostate cancer cell progression in vitro and tumor growth in vivo via miR-497-5p/ACSL1 axis

Jia Chen, Qitong Xie, Weixian Miao et al. · Biochemical and Biophysical Research Communications · 2022 · 12 citations

, , +13

1–4 of 4